Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs

Publisher： Karger

E-ISSN： 1421-9778|37|5|1693-1711

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.37, Iss.5, 2015-0, pp. : 1693-1711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance

By García-Becerra Rocío   Santos Nancy   Díaz Lorenza   Camacho Javier  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2012-12 ,pp. : 108-145

MDPI

Access to resources Recommend Favorite

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer

By Mathe Andrea   Scott Rodney J.   Avery-Kiejda Kelly A.  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-11 ,pp. : 28347-28376

MDPI

Access to resources Recommend Favorite

The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling

By Akl Mohamed R.   Foudah Ahmed I.   Ebrahim Hassan Y.   Meyer Sharon A.   Sayed Khalid A. El  

Marine Drugs, Vol. 12, Iss. 4, 2014-04 ,pp. : 2282-2304

MDPI

Access to resources Recommend Favorite

The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression

By Hawa Zuhair   Haque Inamul   Ghosh Arnab   Banerjee Snigdha   Harris LaCoiya   Banerjee Sushanta K.  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-05 ,pp. : 809-809

MDPI

Access to resources Recommend Favorite

miRNAs and ovarian cancer: An overview

By  

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 233, Iss. 5, 2018-05 ,pp. : 3846-3854

John Wiley & Sons Inc

Access to resources Recommend Favorite